Intermittent Fasting Reduces Body Weight Versus Ad Libitum Diet

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 30, 2025.

via HealthDay

MONDAY, June 30, 2025 -- Intermittent-fasting strategies yield small reductions in body weight compared with an ad libitum diet, according to a study published online June 18 in The BMJ.

Zhila Semnani-Azad, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined the effect of intermittent-fasting diets with continuous energy restriction or unrestricted (ad libitum) diets on intermediate cardiometabolic outcomes in a systematic review and network meta-analysis. The study included 99 randomized clinical trials involving 6,582 adults.

The researchers found that when compared with an ad libitum diet, all intermittent-fasting and continuous energy restriction diet strategies reduced body weight. Alternate-day fasting was the only form of intermittent-fasting diet strategy to show benefit in body weight reduction compared with continuous energy restriction (mean difference, −1.29 kg). Alternate-day fasting showed a trivial reduction in body weight when compared with both time-restricted eating and whole-day fasting (mean difference, −1.69 and −1.05 kg). Among trials with less than 24 weeks follow-up, estimates were similar, but benefits in weight reduction were only seen in diet strategies compared with ad libitum in moderate-to-long-term trials (≥24 weeks). Compared with time-restricted eating, alternate-day fasting lowered total cholesterol, triglycerides, and nonhigh-density lipoprotein in comparisons between intermittent-fasting strategies. Time-restricted eating resulted in a small increase in total cholesterol, low-density lipoprotein cholesterol, and nonhigh-density lipoprotein cholesterol compared with whole-day fasting.

"In our analysis, intermittent-fasting strategies showed trivial to small improvements in body weight reduction," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-01 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords